CAM
VRTX icon

ClariVest Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

ClariVest Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.17M Hold
4,632
– – 0.22% 126
2024
Q2 		$2.17M Sell
4,632
-40
-0.9% -$17.4K 0.22% 126
2024
Q1 		$1.95M Sell
4,672
-10,900
-70% -$4.61M 0.2% 141
2023
Q4 		$6.34M Sell
15,572
-3,073
-16% -$1.14M 0.35% 58
2023
Q3 		$6.48M Sell
18,645
-1,206
-6% -$422K 0.35% 61
2023
Q2 		$6.99M Sell
19,851
-3,500
-15% -$1.18M 0.35% 64
2023
Q1 		$7.36M Sell
23,351
-700
-3% -$210K 0.33% 67
2022
Q4 		$6.95M Buy
+24,051
New +$7.33M 0.33% 73
2021
Q3 		– Sell
-2,300
Closed -$464K – 833
2021
Q2 		$464K Sell
2,300
-54,872
-96% -$11.5M 0.02% 436
2021
Q1 		$12.3M Sell
57,172
-6,100
-10% -$1.34M 0.43% 54
2020
Q4 		$15M Sell
63,272
-10,163
-14% -$2.33M 0.51% 46
2020
Q3 		$20M Buy
73,435
+27,173
+59% +$7.5M 0.65% 33
2020
Q2 		$13.4M Buy
46,262
+43,035
+1,334% +$11.7M 0.37% 62
2020
Q1 		$767K Sell
3,227
-200
-6% -$45.9K 0.02% 338
2019
Q4 		$750K Buy
+3,427
New +$694K 0.02% 386
2013
Q4 		– Sell
-69,739
Closed -$5.29M – 657
2013
Q3 		$5.29M Buy
69,739
+12
+0% +$955 0.24% 99
2013
Q2 		$5.57M Buy
+69,727
New +$5.13M 0.25% 107

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

ClariVest Asset Management's VRTX Position: Q3 2024 in Review

ClariVest Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2024 at 4,632 shares worth $2.17M. The position accounts for 0.22% of the portfolio, ranked #126.

ClariVest Asset Management first reported a position in VRTX in Q2 2013 and has held it in 17 quarters since. The position peaked at $20M in Q3 2020. 1,547 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • ClariVest Asset Management held 4,632 shares of Vertex Pharmaceuticals worth $2.17M as of Q3 2024.
  • ClariVest Asset Management left its Vertex Pharmaceuticals share count unchanged in Q3 2024.
  • Vertex Pharmaceuticals made up 0.22% of ClariVest Asset Management's portfolio in Q3 2024, its #126 holding.
  • ClariVest Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • ClariVest Asset Management's Vertex Pharmaceuticals position peaked at $20M in Q3 2020.
  • 1,547 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.